Research Terms
These silk nanoparticles encapsulate oxygen carriers to maintain soluble oxygen content of perishable biologics in storage and transportation. Donated blood is an essential resource often wasted because of deficient refrigeration, contamination with viruses, and a short shelf life of only 42 days. Currently, the cold-chain system is the most common method of storing bioactive materials such as vaccines, labile drugs, and donated blood. Any deviation from specified temperatures while in storage or transportation can affect the viability of blood and reduce clinical benefits . Interruptions in the cold-chain system waste nearly 272,000 units donated blood each year.
Researchers at the University of Florida have developed silk fibroin nanoparticles to encapsulate and preserve oxygen carriers such as hemoglobin proteins. These silk nanoparticles provide a long-term and inexpensive method of transporting and storing oxygen carriers, mitigating the need for pathogen inactivation and the cold-chain system.
Silk nanoparticles that enclose oxygen carrier hemoglobin and other bioactive molecules, preserving donor blood or other perishable biologics in transportation and storage, while also limiting opportunities for introduction of pathogens.
These silk fibroin particles encapsulate and protect oxygen carriers such as hemoglobin enabling room temperature storage and use as an artificial blood substitute. Lipid micelle encapsulation or phase separation using polyvinyl alcohol enable the creation of the silk particles.
Silk fibroin is a well-established biomaterial known for its strength, biocompatibility, and biodegradability. Biopolymers are investigated for biomaterial fabrication as an alternative to synthetic polymers, reducing the production of environmental pollutants and use of non-renewable resources. Within the class of biopolymers, polymers can be directly produced by a living organism or synthetically produced to mimic the natural polymer. Traditionally sourced from Bombyx mori, its use in biomedical applications is limited by processing constraints and uniformity in material properties. This has prompted explorations into composite materials, chemical modification, and molecular engineering of silk proteins to tailor properties for desired functions.
Silk from species sch as spiders, hornets, and other silkworms differ in protein properties. However, challenges with using these proteins, such as scale of production, safe rearing protocol, and knowledge gaps in protein production, properties, and translation to material formats limit their development in the biomaterial field. Emerging research has identified Plodia interpunctella (Pi)—a common pantry moth—as a novel source of silk fibroin with distinct structural and mechanical characteristics. This organism is a small common agricultural pest. However, scalable methods for processing and solubilizing this silk into functional biomaterial scaffolds are lacking.
Researchers at the University of Florida have described Plodia interpunctella (Pi)as an alternative silk source. It is suitable for the downstream production of raw materials for biomaterial fabrication that are customizable to desired applications through a balance of fiber properties, silk processing, and controlled growth of the organism.
Silk fibroin from Plodia interpunctella for tissue engineering, regenerative medicine, and biomedical device integrations
The patented process involves extracting silk fibroin from Plodia interpunctella, a new source of silk fibronin, and forming it into porous scaffolds through a controlled fabrication method. To make this material useful the technology solubilizes the silk into an aqueous solution and purification. The resulting material exhibits tunable mechanical strength and porosity, allowing for tailoring scaffold properties to specific tissue engineering needs. This technology opens new avenues for silk-based biomaterials beyond traditional sources, expanding the toolkit for regenerative medicine and biomedical engineering.
PO BOX 116005 DEPARTMENT OF CHEMICAL ENGINEERING 1030 CENTER DR GAINESVILLE, Fl 326112023